ArticleLeukemia2026

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

Thierry Facon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.